For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. The USPSTF recommends providing interventions during pregnancy and after birth to support breastfeeding.Ĭervical Cancer: Screening: women aged 21 to 65 years †īreastfeeding: Primary Care Interventions: pregnant women, new mothers, and their children The USPSTF recommends biennial screening mammography for women aged 50 to 74 years.
The USPSTF recommends that clinicians offer to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication effects.īreast Cancer: Screening: women aged 50 to 74 years Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.īreast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged 35 years or older The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. The USPSTF recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.īRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry associated with brca1/2 gene mutation See the Practice Considerations section for information on high risk and aspirin dose.Īsymptomatic Bacteriuria in Adults: Screening: pregnant persons
The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia. The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18 years.Īspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication: pregnant persons at high risk for preeclampsia The USPSTF recommends 1-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked.Īnxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years Print PDF TopicĪbdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked A listing of all the Recommendations with a grade of either A or B.
0 kommentar(er)
